RealTime Software Solutions Reports Record Growth in 2023, Emerging as the Premier Clinical Trial Management Solution for Clinical Research Sites
Retrieved on:
Wednesday, January 17, 2024
Stephen Johnson, CEO of RealTime Software Solutions, reflects on the landmark year, stating, "The previous year has been transformative for RealTime.
Key Points:
- Stephen Johnson, CEO of RealTime Software Solutions, reflects on the landmark year, stating, "The previous year has been transformative for RealTime.
- This evolution is a testament to our team's commitment to improving clinical trial management with state-of-the-art eClinical solutions."
- Exponential User Adoption: Adopted by over 3,000 clinical research sites worldwide, RealTime has experienced a rapid surge in user growth.
- Collaborations with clinical research sites worldwide have contributed to the platform's widespread adoption and recognition as a global leader in clinical trial management solutions.